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Abstract
Background: Previous studies suggest that oxidative stress plays an important role in the development of breast
cancer. There is a significant inverse relationship between HDL and the risk and mortality of breast cancer.
However, it is well known that under conditions of oxidative stress, such as breast cancer, HDL can be oxidatively
modifiedand these modifications may have an effect on the functions of HDL. The purpose of this study is to
determine the different effects of normal and oxidized (caused by hypochlorite-induced oxidative stress) HDL on
breast cancer cell metastasis.
Methods: Human breast cancer cell lines were treated with normal and hypochlorite-oxidized HDL, and then cell
metastasis potency in vivo and the abilities of migration, invasion, adhesion to HUVEC and ECM in vitro were
examined. Integrin expression and PKC activity were evaluated, and PKC inhibitor and PKC siRNA was applied.
Results: We found hypochlorite-oxidized HDL dramatically promotes breast cancer cell pulmonary metastasis
(133.4% increase at P < 0.0 l for MDA-MB-231 by mammary fat pad injection; 164.3% increase at P < 0.01 for MCF7
by tail vein injection) and hepatic metastasis (420% increase at P < 0.0 l for MDA-MB-231 by mammary fat pad
injection; 1840% fold increase at P < 0.001 for MCF7 by tail vein injection) in nude mice, and stimulates higher cell
invasion (85.1% increase at P < 0.00 l for MDA-MB-231; 88.8% increase at P < 0.00 l for MCF7;), TC-HUVEC adhesion
(43.4% increase at P < 0.00 l for MDA-MB-231; 35.2% increase at P < 0.00 l for MCF7), and TC-ECM attachment
(41.0% increase at P < 0.00 l for MDA-MB-231; 26.7% increase at P < 0.05 for MCF7) in vitro compared with normal
HDL. The data also shows that the PKC pathway is involved in the abnormal actions of hypochlorite-oxidized HDL.
Conclusions: Our study demonstrated that HDL under hypochlorite-induced oxidative stress stimulates breast
cancer cell migration, invasion, adhesion to HUVEC and ECM, thereby promoting metastasis of breast cancer. These
results suggest that HDL-based treatments should be considered for treatment of breast cancer patients.
Keywords: Breast cancer, Oxidative stress, Metastasis, High-density lipoprotein
Background
Breast cancer is the most common malignant neoplasm
among women worldwide, and is one of the leading
causes of cancer-related death [1]. Annually, about one
million women are newly diagnosed with breast cancer
and 400,000 patients die from the disease [2]. The etiol-
ogy of breast cancer is multifactorial. It is suggested that
oxidative stress which is responsible for protein, lipid
and DNA damage plays an important role in the devel-
opment and progression of breast cancer [3]. Hypo-
chlorite is an important ROS, which can be released by
activated white blood cells in different diseases during
pro-inflammatory states [4]. However, the role of oxida-
tive stress in the progression of breast cancer is not
fully understood.
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tumor-related morbidity and mortality [5,6]. It is a mul-
tistep process in which tumor cells migrate and invade
into adjoining cells and tissues, attach to subendothelial
extracellular matrix (ECM) and endothelial cells of
blood vessels, and proliferate at other sites to establish
secondary tumors [7]. Many of these steps involve integ-
rins, a glycoprotein family which consist of an a subunit
noncovalently linked to a b subunit [8]. Integrins have
been implicated in a wide variety of cellular functions,
including cell migration, invasion, adhesion, proliferation
and survival [8,9]. Another factor that is has been shown
to be involved in the signaling pathways that regulate
tumor cell proliferation, differentiation, apoptosis, moti-
lity and adhesion is the serine/threonine kinase protein
kinase C (PKC) [10,11]. Interestingly, PKC activity has
been shown to be important in the regulation of integ-
rins expression, localization [12,13] and activity [14].
High-density lipoprotein (HDL), a heterogeneous class
of lipid- and protein- containing plasma particles, is
commonly known for its atheroprotective functions
[15,16]. Furthermore, it has been reported that HDL
levels are inversely related to the incidence of various
cancer, including breast cancer [17-20]. However, sev-
eral studies have shown that the modification of HDL
can impair its atheroprotective functions [21,22]. For
instance, we previously found that HDL of patients with
type 2 diabetes mellitus elevates the capability of HDL
to promote metastasis of breast cancer in vivo [23], and
stimulate cell proliferation, migration, invasion, adhesion
to HUVEC and attachment to EC in vitro [24]. More-
over, oxidative stress could lead to lipid peroxidation
and protein modification, and such changes may signifi-
cantly affect the functions of HDL.
In the present study, we investigated how hypochlor-
ite-oxidized HDL (which was produced in vitro to
mimic the alteration of HDL under oxidative stress) dif-
ferentially affects the metastatic progression of human
breast cancer cells in vivo compared with normal HDL.
In order to more fully understand the mechanisms of
these actions, both the levels of integrins and the PKC
pathway were measured. Our findings may contribute to
the understanding of the relationship between oxidative
stress and breast cancer, and promote the need for
HDL-altering therapy in breast cancer patients.
Methods
Animals
4 week old female BALB/c nude mice were obtained
from the animal house, Academy of Military Medical
Sciences, China. Throughout the experiments, mice
were maintained with free access to pellet food and
water. All experimental procedures were approved by
the Ethics Committee of Animal Research, Peking
University Health Science Center, and the investigation
c o n f o r m e dt ot h eG u i d ef o rt h eC a r ea n dU s eo f
Laboratory Animals published by the US National Insti-
tutes of Health (NIH Publication No. 85-23, revised
1996).
Cell lines and cell culture
The hormone-independent MDA-MB-231 and hor-
mone-dependent MCF7 human breast cancer cell lines
were from Cell Resource Center, Institute of Basic Med-
ical Sciences, Chinese Academy of Medical Sciences,
and cultured in Dulbecco’s modified Eagle’sm e d i u m
(DMEM; GIBCO, UK) containing 10% fetal bovine
s e r u m( F B S ;G I B C O ,U K )i nah u m i d i f i e di n c u b a t o ra t
37°C with an atmosphere of 5% CO2. Human umbilical
vein endothelial cells (HUVEC) were isolated by collage-
nase digestion of umbilical veins from fresh cords [25].
The cells were plated on gelatin-coated culture dishes in
Endothelial Cell Medium (ECM; Sciencell, USA) consist-
ing of 500 ml of basal medium, 25 ml of fetal bovine
serum, 5 ml of endothelial cell growth supplement and
5 ml of penicillin/streptomycin solution and then cul-
tured in a humidified incubator at 37°C with an atmo-
sphere of 5% CO2. HUVEC were used at passages 2-5.
Isolation and hypochlorite-oxidation of HDL
Fresh, fasting plasma was separated by centrifugation
from peripheral blood obtained from healthy subjects
(referred to as N-HDL). The study protocol was
approved by the local ethics committee. HDL was iso-
lated from fresh plasma by ultracentrifugation, dialyzed
against 3 × 1 L of endotoxin-free PBS (pH = 7.4), steri-
lized with 0.22 μm filter, stored in sealed tubes at 4°C in
dark and used within 2 months [26]. Hypochlorite-oxi-
dized HDL (referred to as H-HDL) performed as
described previously [27]. Briefly, the concentration of
NaOCl was calculated using a molar absorption coeffi-
cient of 350 M
-1 cm
-1 at 292 nm. HDL was incubated
with NaOCl at 37°C for 1 hour and then at 4°C over-
night (oxidant:protein molar ratios = 30:1). Then sam-
ples were dialyzed overnight at 4°C against standard
buffer (10 mM Na phosphate, 100 μM DTPA, pH 7.4).
MTT assay
Cells (3 × 10
3/well) were seeded in 96-well plates and
were subsequently incubated for 12 hours to allow
attachment. Then cells were incubated with HDL (at
100 μg/ml apoA-I) for 12, 24, 48 and 72 hours respec-
tively. 4 hours before the end of incubation, 20 μlo f5
mg/ml MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl
tetrazolium bromide; Ameresco, USA) was added to
each well. At the end of incubation, the medium was
removed and 150 μl/well DMSO was added to solubilize
the formazan. Finally, the optical density of the soluble
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550, BioRad, USA). The average values were determined
from quadruplicate readings.
Wound healing migration assay
Cells were seeded onto 24-well plates and cultured till
to form monolayers, then wounded by manual scraping
with a 200 μl-micropipette tip. Cells were then incu-
bated with medium containing 1%FBS alone or together
with indicated concentrations of HDL for 24 hours (for
MDA-MB-231 cells) or 48 hours (for MCF7 cells). Cells
were fixed with methanol, stained with hematoxylin and
eosin, and photographed with an inverted microscope
(Nikon, Japan). Cell migration was quantified by count-
ing the number of cells that migrated into the gap in 10
random high power (100×) fields.
Transwell migration assay
Quantitative cell migration assay was performed using a
modified Boyden chamber (Minicell, Millipore, USA)
with 8.0-μm pore polycarbonate filter inserts in 24-well
plates. The lower chamber was filled with 0.6 ml of
DMEM containing 10% FBS. Cells (1 × 10
5 cells/well) in
serum-free medium were plated into the upper chamber
with DMEM alone or with indicated concentrations of
HDL. After 6 hours (for MDA-MB-231 cells) or 18
hours (for MCF7 cells) incubation, all non-migrated
cells were removed from the upper face of the transwell
membrane by a cotton swab, and the migrated cells
were fixed with methanol, stained with hematoxylin and
eosin, and photographed under an inverted microscope
(Nikon, Japan). Migration was quantified by counting
the number of stained cells from 10 random high power
(100×) fields.
Transwell invasion assay
Quantitative cell invasion assay was performed using a
modified Boyden chamber (Minicell, Millipore, USA)
with 8.0-μm pore polycarbonate filter inserts in 24-well
plates. The lower face of the polycarbonate filter (trans-
well insert) was coated with 20 μlM a t r i g e l( B D
Bioscience, Germany) for one hour at 37°C and then air
dry. The lower chamber was filled with 0.6 ml of DMEM
containing 10% FBS. Cells (1 × 10
5 cells/well) in serum-
free medium were plated into the upper chamber with or
without indicated concentrations of HDL. After 18 hours
(for MDA-MB-231 cells) or 24 hours (for MCF7 cells)
incubation, all non-invading cells were removed from the
u p p e rf a c eo ft h et r a n s w e l lm e m b r a n eb yac o t t o ns w a b ,
and the invaded cells were fixed with 10% formalin,
stained with hematoxylin and eosin, and photographed
under an inverted microscope (Nikon, Japan). Invasion
was quantified by counting the number of stained cells
from 10 random high power (100×) fields.
TC-HUVEC adhesion assay
TC-HUVEC adhesion was measured using rose Bengal
stain as previously described method [28]. Briefly,
HUVEC were seeded onto 96-well plates at a density of
5×1 0
4 cells/well. Then tumor cells (pretreated with or
without HDL for 6 hours) were plated (5 × 10
4 cells/
well) and incubated for 30 minutes at 37°C. Then unat-
tached cells were gently washed twice with 10% FBS-
containing DMEM, and 100 μl of 0.25% rose Bengal
(Sigma, USA) was added. After 5 minutes, cells were
gently washed twice, and then 200 μle t h a n o l / P B S( 1 : 1 )
was added to each well. After 30 minutes, the absor-
bance at 570 nm was recorded. Five parallel wells were
set up for each group.
TC-ECM adhesion assay
Cell adhesion was measured using MTT assay as pre-
viously described method [29]. Briefly, 96-well flat bot-
tom plates were coated with 2 μg/well basement
membrane matrix (Matrigel, BD, Germany) for a hour
at 37°C then blocked with 2% BSA for 2 hours at 37°C
followed by washing twice. Tumor cells seeded on 12-
well plate were treated with serum-free DMEM alone or
HDL for 6 hours. After detachment with trypsin, the
cells (1 × 10
4/well) were plated on ECM-precoated 96-
well plates and then washed twice with PBS to remove
non-adherent cells after 45 minutes. MTT colorimetric
assays at 490 nm were employed to measure the absor-
bance of adhesive cells. Four parallel wells were set up
for each group.
Determination of cell surface expression of adhesion
molecules by enzyme immunoassay
Cells in 96-well plates were grown till 70% confluency,
then treated with normal or oxidized HDL in serum-
free medium for 6 hours at 37°C. Cells were washed
with PBS and fixed with methanol for 5 minutes and
then washed with PBS 3 times and blocked with 2%
BSA for 2 hours at 37°C. Cell surface expression of
adhesion molecules were determined by primary binding
with specific monoclonal antibodies for integrin b1,
integrin b2, integrin b3, integrin av (1:200; Abcam,
Hong Kong) followed by secondary binding with a
horseradish peroxidase-conjugated antibody (1:3000;
Boster, China) as described previously [30]. Quantifica-
tion was performed by determination of colorimetric
conversion at an optical density at 450 nm of 3,3,5,5-tet-
ramethylbenzidine using TMB peroxidase EIA substrate
kit (Bio-Med innovation, China).
PepTag assay for nonradioactive detection of PKC activity
The PKC activity in the MDA-MB-231 and MCF7 cell
lysates was determined by non-radioactive detection kit
of protein kinase (PepTag Corporation, USA), following
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HDL-treated cell lysates was separated by column of
DEAE cellulose and was incubated with the brightly
colored, fluorescent peptide substrates. Then phosphory-
lation by PKC of its specific substrate alters the pep-
tide’s net charge from +1 to -1, which allows the
phosphorylated and non-phosphorylated versions of the
substrate to be rapidly separated on an agarose gel. For
quantification, the blots were analyzed using Gel-Pro
analyzer 3.0 software and quantification was based on
the IOD (Integrated Optical Density) value of each
band.
siRNA knockdown of PKC
MDA-MB-231 cells were plated onto 6-well plates and
allowed to grow to sub-confluent. Cells were transiently
transfected with negative control siRNA or PKC siRNA
(Santa Cruz, America) by lipofectamine RNAi MIX
reagent (Invitrogen, America) in OPTI-MEM medium
(Gibco, America) for 6 h, and then incubated in ECM
with 5% FBS. Cells were prepared to be used for further
experiments.
Tail vein metastasis model
MCF7 cells were pretreated with normal and oxidized
HDL for 24 hours. To produce experimental metastasis,
BALB/c nude mice (6 mice were set for each group)
were injected intravenously with MCF7 cells (4 × 10
5)
in 0.2 ml DMEM via tail veins. After 20 days, the mice
were sacrificed, their lungs and livers were resected and
photographs were taken. Numbers of metastatic nodules
on the surface of the lungs and livers were counted.
Mammary fat pad spontaneous metastasis model
MDA-MB-231 cells were pretreated normal and oxidized
HDL for 24 hours and then 2 × 10
6 cells suspended in
DMEM were injected into the mammary fat pad. BALB/c
nude mice (6 mice were set for each group) were received
normal or oxidized HDL injection through vein tail every
three days. After 40 days, the mice were sacrificed, their
lungs and livers were resected and photographs were
taken. Numbers of metastatic nodules on the surface of
the lungs and livers were counted.
Histology
Tissues were fixed in buffered formalin for 24-48 h. After
washing in fresh PBS, fixed tissues were processed and
embedded in paraffin. Sections (5 milli micron) were col-
lected on microscope slides, deparaffinized and stained
with H&E. The images were captured at 10x magnification.
Statistical analysis
The results of multiple observations are presented as the
mean ± SEM and as a representative result of three
different separate experiments unless otherwise stated.
Data were analyzed using Student’stt e s ta n dA N O V A
test and values were considered significant at P < 0.05.
Results
Hypochlorite-modified HDL is significantly more effective
in stimulating breast cancer cell proliferation, migration
and invasion
We first determined the effects of N-HDL and H-HDL
on cell proliferation in two different breast cancer cell
lines. MDA-MB-231 and MCF7 cells were incubated
with N-HDL and H-HDL for 12, 24, 48 and 72 hour at
100 μg/ml apoA-I. It was found that both N-HDL and
H-HDL stimulated MDA-MB-231 and MCF7 cell prolif-
eration in a time dependent manner (P <0 . 0 0l ;F i g u r e
1A, B). Of note, H-HDL presented to be a more power-
ful stimulant of proliferation for both MDA-MB-231
(Figure 1A) and MCF7 cells (Figure 1B). For MDA-MB-
231 cells, cell proliferation induced by H-HDL increased
by 6.9% at 24 hours (P < 0.05), 16.4% at 48 hours (P <
0.0 l) and 21.0% at 72 hours (P <0 . 0 0l )c o m p a r e dw i t h
N-HDL. For MCF7 cells, cell proliferation induced by
H-HDL increased by 14.5% at 72 hours (P <0 . 0 5 )c o m -
pared with N-HDL.
We further investigated the effects of N-HDL and H-
HDL on the cell migration and invasion of MDA-MB-
231 and MCF7 cell lines. It was shown that H-HDL pro-
motes MDA-MB-231 and MCF7 cell migration and
invasion while N-HDL was inhibitory. For MDA-MB-
231 cells, the migration induced by H-HDL increased by
111.9% and 82.0% in the transwell migration assay and
by 110.1% and 91.7% in the wound healing assay com-
pared with N-HDL and control respectively (both at P <
0 . 0 0l ;F i g u r e1 C ,D ,E ,F ) .I na d d i t i o n ,t h ei n v a s i v e
MDA-MB-231 cells induced by H-HDL increased by
85.1% and 74.8% in the transwell invasion assay com-
pared with N-HDL and control respectively (both at P <
0.00 l; Figure 1G, H). For MCF7 cells, the migration
induced by H-HDL increased by 75.3% and 66.8% in
transwell migration assay and by 57.5% and 41.1% in
wound healing assay compared with N-HDL and control
respectively (both at P < 0.00 l; Figure 1C, D, E, F). In
addition, the invasive MDA-MB-231 cells induced by H-
HDL increased by 88.8% and 48.4% in transwell invasion
assay compared with N-HDL and control respectively (P
< 0.00 l for N-HDL and P < 0.0 l for control; Figure 1G,
H).
Breast cancer cells pretreated with hypochlorite-modified
HDL have increased capacities of adhesion to HUVEC and
attachment to ECM
The effects of N-HDL and H-HDL on MDA-MB-231
and MCF7 cell adhesion to HUVEC and attachment to
ECM was tested. It was shown that the adhesion of
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2A) and ECM (Figure 2B) pretreated with H-HDL was
markedly increased compared to cells pretreated with
N-HDL and control. In the TC-HUVEC adhesion assay,
the adhesion of MDA-MB-231 cells pretreated with H-
HDL increased by 43.4% and 36.4% as compared with
Figure 1 H-HDL is more effective in stimulating MDA-MB-231 and MCF7 cell proliferation, migration and invasion. MDA-MB-231 (a) and
MCF7 (b) were treated with N-HDL and H-HDL respectively for 12, 24, 48, 72 hours at 100 μg/ml apoA-I. Relative cell proliferation was measured
by MTT assay and expressed as percentage of HDL treated cells in comparison to control. (*, P < 0.05; **, P < 0.01; ***, P < 0.001; one-way
ANOVA). (c) MDA-MB-231 and MCF7 cells were incubated with N-HDL and H-HDL respectively at 100 μg/ml apoA-I in upper chamber for
indicated time. Transwell assay was used to measure cell migration and pictures were shown in high power (100×). (d) Migrated cells were
counted and the results were expressed as percentage of HDL treated cells in comparison to control. (***, P < 0.001; one-way ANOVA). (e)
Monolayer MDA-MB-231 and MCF7 cells were wounded by manual scraping and incubated with N-HDL and H-HDL respectively at 100 μg/ml
apoA-I for indicated time and then photographed in high power (100×). (f) Cells migrated into the gaps were counted and the results were
expressed as percentage of HDL treated cells in comparison to control. (***, P < 0.001; one-way ANOVA). (g) MDA-MB-231 and MCF7 cells were
treated with N-HDL and H-HDL respectively in upper chamber for indicated time at 100 μg/ml apoA-I. Transwell assay was used to measure cell
invasion and pictures were shown in high power (100×). (h) Invasive cells were counted and the results were expressed as percentage of HDL
treated cells in comparison to control. (**, P < 0.01; ***, P < 0.001; one-way ANOVA).
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ure 2A). Similarly, the adhesion of MCF7 cells pre-
treated with H-HDL increased by 35.2% and 28.0% as
compared with N-HDL and control respectively (both at
P < 0.00 l; Figure 2A). In the TC-ECM adhesion assay,
the attachment of MDA-MB-231 cells pretreated with
H-HDL increased by 41.0% and 35.2% as compared with
N-HDL and control respectively (both at P < 0.001; Fig-
ure 2B). Similarly, the attachment of MCF7 cells pre-
treated with H-HDL increased by 26.7% and 19.9% as
compared with N-HDL and control respectively (both at
P < 0.05; Figure 2B).
Integrins are involved in hypochlorite-modified
HDL-induced invasion and adhesion of breast cancer
cells.W ep r e v i o u s l yf o u n di n t e g r i nb1, integrin b2,
integrin b3 and integrin aν play an important role in
the in the adhesion of MDA-MB-231 and MCF7 cells to
HUVEC and ECM by using blocking antibodies to inter-
grins [23]. In the present study, it was found that H-
HDL induced elevated expression levels of integrin b1
(Figure 3A), integrin b2 (Figure 3B), integrin b3( F i g u r e
3C) and integrin av (Figure 3D) compared with N-HDL
on both the MDA-MB-231 and MCF7 cell surface. Spe-
cifically, for MDA-MB-231 cells, integrin b1w a s
increased by 26.4% and 16.6% respectively (both at P <
0.001; Figure 3A); integrin b2 was increased by 13.2%
and 11.7% respectively (both at P < 0.01; Figure 3B);
integrin b3 was increased by 20.3% and 16.0% respec-
tively (both at P <0 . 0 0 1 ;F i g u r e3 C ) ;i n t e g r i navw a s
increased by 20.6% and 22.9% respectively (both at P <
0 . 0 5 ;F i g u r e3 D ) .F o rM C F 7c e l l s ,i n t e g r i nb1w a s
increased by 37.4% and 24.6% respectively (P < 0.001 for
N-HDL, P < 0.01 for control; Figure 3A); integrin b2
was increased by 19.6% and 14.8% respectively (both at
Figure 2 H-HDL promotes more MDA-MB-231 and MCF7 cell adhesion to HUVEC and attachment to ECM. (a) MDA-MB-231 and MCF7
cells were pretreated with N-HDL and H-HDL at 100 μg/ml apoA-I for 6 hours and then seeded onto HUVEC-coated 96-well plate for 30
minutes. Relative cell adhesion was determined by Rose Bengal assay and expressed as percentage of HDL treated cells in comparison to
control. Data is expressed as mean ± SEM with five parallel wells. (**, P < 0.01; ***, P < 0.001; one-way ANOVA). (b) MDA-MB-231 and MCF7 cells
were pretreated with N-HDL and H-HDL at 100 μg/ml apoA-I for 6 hours and then plated onto matrigel-coated 96-well plate for 30 minutes.
Relative cell adhesion was determined by MTT assay and expressed as percentage of HDL treated cells in comparison to control. Data is
expressed as mean ± SEM with four parallel wells. (*, P < 0.05; ***, P < 0.001; one-way ANOVA).
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Page 6 of 13Figure 3 Intergrins are involved in the increased invasion and adhesion of breast cancer cells induced by H-HDL.MDA-MB-231 and
MCF7 cells were treated with N-HDL and H-HDL at 100 μg/ml apoA-I for 6 hours. Integrin b1 (a), integrin b2 (b), integrin b3 (c) and integrin av
(d) levels on the cell surface were measured by cell ELISA with five parallel wells. Results were expressed as percentage of HDL treated cells in
comparison to control and data is expressed as mean ± SEM. (*, P < 0.05; **, P < 0.01; ***, P < 0.001 by one-way ANOVA). (e) MDA-MB-231 cells
were incubated with N-HDL and H-HDL at 100 μg/ml apoA-I along with no antibody, negative control antibody, or anti-integrin (b1, b2, b3, av)
antibodies respectively in upper chamber for 18 hours. (***, P < 0.001; one-way ANOVA). MDA-MB-231 cells were pretreated with N-HDL and H-
HDL at 100 μg/ml apoA-I for 6 hours and then incubated with no antibody, negative control antibody, or anti-integrin (b1, b2, b3, av)
antibodies for 30 minutes at 37°C before the adhesion to HUVEC (f) and attachment to ECM (g). Antibody-blocked groups were compared with
control (antibody-untreated groups). Data is expressed as mean ± SEM with five parallel wells. (**, P < 0.01; ***, P < 0.001; one-way ANOVA).
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and 16.4% respectively (P <0 . 0 1f o rN - H D L ,P <0 . 0 5
f o rc o n t r o l ;F i g u r e3 C ) ;i n t e g r i nav was increased by
13.8% and 7.9% respectively (P <0 . 0 1f o rN - H D L ,P <
0.05 for control; Figure 3D). Furthermore, after treat-
ment with blocking antibodies to integrins, MDA-MB-
231 cells invasion (Figure 3E), adhesion to HUVEC (Fig-
ure 3F), and attachment to ECM (Figure 3G) was dra-
matically reduced in all the control, N-HDL and H-HDL
groups.
PKC inhibitor significantly reduces hypochlorite-modified
HDL-induced migration, invasion and adhesion of MDA-
MB-231 and MCF7 cells
It has been reported that the activity of PKC plays a
vital role in regulating tumor development including cell
migration, invasion and adhesion and etc. Therefore, the
ability of N-HDL and H-HDL to induce PKC activity
was examined. It was found that H-HDL stimulated
higher PKC activity compared with N-HDL both in
MDA-MB-231 and MCF7 cells (Figure 4A). These
results suggest that H-HDL may promote breast cancer
cell metastasis via the PKC pathway. In order to test
this, MDA-MB-231 and MCF7 cells were treated with
staurosporine, a PKC inhibitor, in order to determine
the role of PKC pathway in the cell migration, invasion
and adhesion promoted by H-HDL. Staurosporine is a
powerful inhibitor of breast cancer cell migration (Fig-
ure 4B), invasion (Figure 4C), adhesion to HUVEC (Fig-
u r e4 D )a n dt oE C M( F i g u r e4 E). After pretreatment
with staurosporine, the H-HDL stimulated MDA-MB-
231 and MCF7 cell migration, invasion, adhesion to
both HUVEC and ECM was substantially reduced, and
no statistical significance was found among the groups
of staurosporine-pretreated cells in all the above assays.
siRNA targeted at PKC significantly reduces hypochlorite-
modified HDL-induced invasion, adhesion and integrins
expression of MDA-MB-231 cells
PKC siRNA was applied further to investigate the role of
PKC in the H-HDL induced invasion, adhesion and
integrins expression of breast cancer cell. The effect of
PKC siRNA on the cellular PKC expression was shown
(Figure 5A). H-HDL induced MDA-MB-231 cell inva-
sion (Figure 5B), adhesion to HUVEC (Figure 5C) and
attachment to ECM (Figure 5D) was dramatically
reduced, and no statistical significance was found
among the groups of PKC siRNA cells in all the above
assays. In addition, MDA-MBV-231 cells transfected
with PKC siRNA showed a substantial decrease in the
integrins expression even after treated with H-HDL (Fig-
ure 5E, F, G, H). These results taken together suggests
that the increased abilities of H-HDL to promote MDA-
MB-231 and MCF7 cell migration, invasion, and
adhesion to HUVEC and ECM is mainly owing to the
increased level of PKC.
Hypochlorite-modified HDL promotes breast cancer cell
metastasis in vivo
The above data indicates that N-HDL has an elevated
ability to promote breast cancer cells proliferation,
migration, invasion and adhesion to both HUVEC and
ECM compared with N-HDL in vitro. In order to deter-
mine if these effects also occur in vivo, we utilized a tail
vein metastasis model and a mammary fat pad sponta-
neous metastasis model to check the metastasis ability
of HDL-treated MCF7 cells in nude mice (Figure 6A).
For the tail vein metastasis model, H-HDL significantly
promoted both pulmonary and hepatic metastasis of
MCF7 cells as was observed by an increase in the
n o d u l e so nt h el u n g so fH - H D Lg r o u pb y1 6 4 . 3 %a n d
117.6% as compared with that of N-HDL and control
(both at P < 0.01; Figure 6B). In addition, the nodules
on the livers of H-HDL group increased by 1840% and
281.6% compared with that of N-HDL and control (both
at P < 0.001; Figure 6C). On the contrary, N-HDL
reduced metastasis of MCF7 cells in the liver by 80.3%
as compared with control (P < 0.05; Figure 6C). The
results from the mammary fat pad spontaneous metasta-
sis model are very similar. The data indicated that H-
HDL significantly promote both lung and liver homing
of MDA-MB-231 cells (Figure 6E). The nodules on the
lungs of H-HDL group increased by 133.4% and 93.1%
(both at P < 0.01; Figure 6F) and the nodules on the
livers of H-HDL group increased by 420% and 123.4%
compared with that of N-HDL and control (P < 0.01 for
N-HDL and P < 0.05 for control; Figure 6G). Represen-
tative histological photomicrographs of lung and liver
tissue sections stained with H&E (Figure 6D, H).
Discussion
Previous studies suggest that breast cancer patients are
exposed to conditions of oxidative stress [31,32]. Oxida-
tive stress is caused by excess generation of reactive
oxygen species (ROS) and/or decreased antioxidant level
in the target cells and tissues and is closely related to all
aspects of cancer, from carcinogenesis treatment and
prevention [33]. ROS are capable of altering all major
classes of biomolecules, such as lipids, nucleic acids and
proteins. These changes may not only alter the structure
of these molecules but may also change the function
[34]. Furthermore, there is a growing evidence for an
involvement of lipids, lipid metabolism and lipid peroxi-
dation in breast cancer development [35-37]. Lipid
alterations and the susceptibility of lipoproteins to oxi-
dation may play important roles in breast cancer. Sev-
eral studies have demonstrated that there are significant
changes in serum lipids and lipoproteins in cancer
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Page 8 of 13Figure 4 H-HDL stimulates MDA-MB-231 and MCF7 cell migration, invasion and adhesion involving PKC pathway. (a)MDA-MB-231 and
MCF7 cells were treated with N-HDL and H-HDL for 30 minutes at 100 μg/ml apoA-I, and then the cell lysates were subjected to the PepTag
nonradioactive PKC assay. (b, c) MDA-MB-231 and MCF7 cells were preincubated with 5 nM staurosporine, a PKC inhibitor along with N-HDL
and H-HDL at 100 μg/ml apoA-I respectively for indicated hours (6 hours for MDA-MB-231 and 18 hours for MCF7 in transwell migration assay;
18 hours for MDA-MB-231 and 24 hours for MCF7 in transwell invasion assay). Migrated cells (b) and invasive cells (c) were counted and the
results were expressed in comparison to control. (***, P < 0.001; student’s t-test).(d, e) MDA-MB-231 and MCF7 cells were pretreated with 5 nM
staurosporine, a PKC inhibitor, for 3 hours and then along with N-HDL and H-HDL at 100 μg/ml apoA-I respectively for another 6 hours. Cell
adhesion to HUVEC (d) and attachment to ECM (e) were measured. (***, P < 0.001; student’s t-test).
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Page 9 of 13Figure 5 The effect of silencing PKC on the invasion, adhesion and integrins expression of MDA-MB-231breast cancer cells. MDA-MB-
231 cells were left untreated or transfected with scramble siRNA (control siRNA) or siRNA for PKC (PKC siRNA), and then were incubated with N-
HDL and H-HDL respectively for indicated hours as previously described. The effect of control siRNA and PKC siRNA on the protein expression of
PKC subtypes was determined by western blot (a). Cell invasion (b), adhesion to HUVEC (c), attachment to ECM (d), and integrin levels (e, f, g,
h) on the cell surface were examined. (*, P < 0.05; **, P < 0.01; ***, P < 0.001; one-way ANOVA).
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Page 10 of 13patients. These changes include elevated plasma lipid
level such as total lipids, triglycerides, total cholesterol,
LDL and free fatty acids (FFA) along with low concen-
trations of HDL [38,39]. Despite these observations, the
relationship between oxidative stress and breast cancer
is still not clear. The purpose of this report is to provide
a study of the effect of hypochlorite-oxidized HDL on
the promotion of breast cancer development and to
Figure 6 H-HDL promotes pulmonary and hepatic metastasis of MDA-MB-231 and MCF7 cells in vivo. (a) MDA-MB-231 and MCF7 cells
were pretreated with N-HDL and H-HDL for 24 hours then 4 × 10
5 cells were intravenously injected into BALB/c nude mice via tail vein. After
20 days, lungs and livers were resected and analyzed for metastasis. Representative pictures of lungs and livers were shown. (b, c) Quantitative
evaluation of detectable nodules on the surface of the whole lungs and livers was shown. Data is expressed as mean ± SEM. (*, P < 0.05; **, P <
0.01; ***, P < 0.001; one-way ANOVA). (d) Representative histological photomicrographs of lung and liver tissue sections stained with H&E (10×).
Arrows indicate tumor islands. (e) MDA-MB-231 and MCF7 cells were pretreated with N-HDL and H-HDL for 24 hours then 2 × 10
6 cells were
injected into the mammary fat pad. BALB/c nude mice were received normal or oxidized HDL injection through vein tail every three days. After
40 days, lungs and livers were resected and analyzed for metastasis. Representative pictures of lungs and livers were shown. (f, g) Quantitative
evaluation of detectable nodules on the surface of the whole lungs and livers was shown. Data is expressed as mean ± SEM. (*, P < 0.05; **, P <
0.01; one-way ANOVA). (h) Representative histological photomicrographs of lung and liver tissue sections stained with H&E (10×). Arrows indicate
tumor islands.
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Page 11 of 13demonstrate the significantly different effects between
hypochlorite-oxidized HDL and normal HDL on breast
cancer cell metastasis progression.
HDL plays an extremely important role in protecting
the cardiovascular system from atherosclerosis. This
includes HDL’s roles in reverse cholesterol transport
(RCT), along with HDL’s anti-oxidant, anti-inflamma-
tory, anti-thrombotic properties [15,16]. Of note, HDL
can exert its anti-oxidant activity by inhibiting genera-
tion of reactive oxygen species (ROS) both in vitro
[40,41] and in vivo [42]. The antioxidative activity of
HDL is related to the presence of several apolipopro-
teins (apoA-I, apoE, apoJ, apoA-II and apoA-IV) and
enzymes (PON1, PAF-AH, LCAT, GSPx) with antioxi-
dative properties.
However, HDL was found to be modified in many
ways under certain disease states and these modifica-
tions can impair its functions. We previously found that
HDL in type 2 diabetes mellitus can be modified, and
such modified HDL was found to promote breast cancer
cell metastasis in vivo and increase cell proliferation,
migration, invasion and adhesion s in vitro as compared
with normal HDL [23,24]. Similar to type 2 diabetes,
oxidative stress has been reported to be important in
breast cancer. This taken together with the susceptivity
of HDL to be modified under conditions of oxidative
stress, drove us to speculate that oxidized HDL may
have an altered function in development and progres-
sion of breast cancer.
In our present study, we have utilized both an in vitro
model system, using both hormone-independent (MDA-
MB-231) and hormone-dependent (MCF7) cell lines,
and an in vivo model utilizing both a metastasis model
and a spontaneous metastasis model. The in vitro
experiments demonstrate that hypochlorite-oxidized
HDL can promote cell migration, invasion and adhesion
to HUVEC and ECM. These studies also indicate that
hypochlorite-oxidized HDL can induce higher cell sur-
face expression of integrins and increased activity of
PKC. Moreover, we observed that antibodies against
integrins, PKC inhibitor (staurosporine), and siRNA tar-
geted at PKC can inhibit hypochlorite-oxidized HDL
induced breast cancer cell invasion and adhesion to
HUVEC and ECM. In addition, integrins expression was
regulated by PKC. The present data demonstrates that
the increased capabilities of hypochlorite-oxidized HDL
in promoting breast cancer cell invasion and adhesion
to HUVEC and ECM is mainly due to the elevated PKC
activity.
The in vivo models used in this study include a tail-
vein injection model utilizing MCF7 cells and a spon-
taneous metastatic model utilizing MDA-MB-231 cells.
These experiments clearly show that hypochlorite-oxi-
dized HDL compared with normal HDL, can promote
breast cancer cells metastasis in vivo. The experimental
results from the in vitro and in vivo experiments
allows us to speculate that the promoting effects of
HDL under oxidative stress on breast cancer cell
metastasis, at least partially, may be attributed to the
oxidation of HDL.
The potent oxidant hypochlorite is a highly aggressive
ROS and is capable of inducing lipid peroxidation and
protein oxidation. Importantly, both lipid peroxidation
and protein oxidation in HDL could have potential roles
in neoplastic transformation and development. Due to
the complicated composition of HDL, further intensive
research needs to be focused on the determination of
the oxidatively modified parts of HDL that is responsible
for the promotion of breast cancer development.
Conclusion
Our study demonstrates that the modifications of HDL
that may occur in breast cancer patients could lead to
accelerated breast cancer metastasis and progression.
These results suggest that an additional avenue for the
pursuit of therapeutic strategies for patients with breast
cancer may be based on the adverse effects of oxidized
HDL on breast cancer metastasis.
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